Medical Devices

After a major restructure, Mauna Kea Technologies posts 44% growth, fueled by its Cellvizio imaging platform and a clever cash-pay model for global expansion.

Houston-based TYBR Health lands $30M to scale its B3 GEL System, a novel hydrogel aiming to shift orthopedic surgery from mere repair to managed recovery.

A new FDA-cleared VR therapy for 'lazy eye' is teaming up with Spin Master, turning screen time with shows like PAW Patrol into a medical breakthrough.

Hilo launches its wearable blood pressure system in the U.S., trading the old cuff for continuous data. Is this the future of heart health or a pricey wellness gadget?

A new 'smart' brain implant is revolutionizing Parkinson's care in India, but as experts gather, the promise of this tech meets the reality of access.

With a new CFO known for turnarounds and a new leader for its clinic network, Neuronetics is making a strategic bet on financial discipline and patient care.

Aptyx's appointment of CFO David Price as CEO signals a classic private equity playbook: leveraging financial discipline to drive aggressive growth in medtech.

Celebrating its 200th patent, Route 92 Medical isn't just advancing stroke care; it's building an IP fortress to challenge industry giants.

Precision IO Group is showcasing its AI-guided Epione robot and a vision for remote cancer surgery, aiming to erase geographic barriers to expert care.

A single-collimator system that images all isotopes is more than an upgrade; it's a strategic move to dominate the future of personalized cancer care.

BIOTRONIK Neuro's new AI doesn't just track pain; it anticipates needs, shifting spinal cord stimulation from reactive treatment to proactive, personalized care.

Medtrum's new 300U patch pump enters Germany's key market, challenging rivals with higher capacity and a fully integrated system for patient-centric care.

Spain's ANF Care™ is bringing 'frequency-coded' discs to America. But can a non-invasive patch truly tune our bodies, or is it just high-tech hope?

Cellution Biologics' acquisition of SimpliDerm is more than a simple expansion. It's a tale of two diverging strategies in the high-stakes biologics market.

The vision correction leader posted preliminary Q2 sales over $90M, doubling last year's figures while navigating Mideast turmoil and a rocky ERP rollout.

A $17.5M write-down and a shareholder lawsuit reveal a critical lesson for tech firms: production capacity must align with market demand, or investors will pay the price.

After a staggering 58% stock plunge, diabetes device maker Embecta faces a shareholder lawsuit alleging it misled investors. Here’s why it matters.

A Pittsburgh startup just secured major funding to fix a 60-year-old problem in EMS, potentially saving millions from secondary injuries during ambulance rides.

A Dutch med-tech firm's sutureless device, validated in a key trial, could make bypass surgery faster, safer, and more accessible via robotics.

Bausch + Lomb's EyeGility system aims to make cataract surgery faster and safer. A look at the tech, the competition, and the push for efficiency.